(Q80152299)
Statements
Resistance development over 144 weeks in treatment-naive patients receiving tenofovir disoproxil fumarate or stavudine with lamivudine and efavirenz in Study 903 (English)
N A Margot
B Lu
A Cheng
M D Miller
Study 903 Team
1 October 2006